Data from clinical study of Pharmalink’s Nefecon® to be presented at American Society of Nephrology’s Kidney Week 2014 November 3, 2014 15:27 CET Non Regulatory Read more
Pharmalink extends patent protection for Nefecon® treatment for renal disease October 27, 2014 15:27 CET Non Regulatory Read more
Pharmalink’s core patents for Nefecon® treatment for renal disease granted in United States, Europe, China and Hong Kong July 10, 2014 15:26 CET Non Regulatory Read more
Pharmalink completes enrolment of patients into Phase IIB clinical study (NEFIGAN) of Nefecon® January 13, 2014 15:25 CET Non Regulatory Read more
